TOFACITINIB TREATMENT IS ASSOCIATED WITH ATTAINMENT OF THE MINIMALLY IMPORTANT REDUCTION IN AXIAL MRI INFLAMMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS